CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2020		54,865,092
Beginning balance at Dec. 31, 2020	$ 453,266	$ 55	$ 650,300	$ 239	$ (197,328)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock form the exercise of stock options and settlement of restricted stock units (in shares)		695,122
Issuance of common stock from the exercise of stock options and settlement of restricted stock units	1,849	$ 1	1,848
Stock-based compensation expense	3,909		3,909
Net income (loss)	8,650				8,650
Other comprehensive income (loss), net of tax	(47)			(47)
Ending balance (in shares) at Mar. 31, 2021		55,560,214
Ending balance at Mar. 31, 2021	$ 467,627	$ 56	656,057	192	(188,678)
Beginning balance (in shares) at Dec. 31, 2021	55,900,855	55,900,855
Beginning balance at Dec. 31, 2021	$ 504,928	$ 56	669,223	(175)	(164,176)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock form the exercise of stock options and settlement of restricted stock units (in shares)		585,857
Stock-based compensation expense	4,778		4,778
Net income (loss)	(6,430)				(6,430)
Other comprehensive income (loss), net of tax	$ (1,153)			(1,153)
Ending balance (in shares) at Mar. 31, 2022	56,486,712	56,486,712
Ending balance at Mar. 31, 2022	$ 502,123	$ 56	$ 674,001	$ (1,328)	$ (170,606)